Larrauri Blas J, Torre María Gabriela, Malbrán Eloísa, Juri María Cecilia, Fernández Romero Diego S, Malbrán Alejandro
Unidad de Alergia, Asma e Inmunología Clínica, Buenos Aires, Argentina. E-mail:
Unidad de Alergia, Asma e Inmunología Clínica, Buenos Aires, Argentina.
Medicina (B Aires). 2017;77(5):382-387.
Anaphylaxis during anesthesia is an unpredictable, severe, and rare reaction. It has an incidence of 1/10 000 to 1/20 000 surgeries. In most series, the responsible drugs include neuromuscular blocking agents, latex, or antibiotics. The frequency and etiology of systemic allergic reactions in other medical procedures are largely unknown. The identification of responsible drugs of anaphylaxis is a complex task, requiring testing of all medications and substances used during surgery. We describe our experience in a retrospective study of 15 patients. Ten subjects developed anaphylaxis during surgery, two in endoscopic studies and one in a trans-vaginal ultrasound. The remaining two subjects, one in a trans-vaginal ultrasound and another during a dental procedure had a systemic allergic reaction. We studied all patients with all medications administered during the procedures, including latex and detergents and disinfectants. Three surgeries had to be suspended at induction of anesthesia, five were stopped incomplete and two were completed. Both patients that presented a reaction during endoscopy required intensive care unit admission and the rest were observed in a Hospital. The responsible drugs during surgery anaphylaxis were neuromuscular blocking agents, latex, patent blue, and ranitidine. Ortho-phthalaldehyde (OPA) was identified during endoscopic studies; latex was responsible in transvaginal ultrasounds; and amoxicillin in the dental procedure. The aim of the present article is to review our experience studying allergic systemic reactions and anaphylaxis during general anesthesia and medical procedures, emphasizing the severity of these reactions and the need for causative drug identification.
麻醉期间发生的过敏反应是一种不可预测、严重且罕见的反应。其发生率为每10000至20000例手术中有1例。在大多数系列研究中,引发过敏反应的药物包括神经肌肉阻滞剂、乳胶或抗生素。在其他医疗操作中,全身过敏反应的发生频率和病因在很大程度上尚不清楚。确定过敏反应的责任药物是一项复杂的任务,需要对手术期间使用的所有药物和物质进行检测。我们在一项对15例患者的回顾性研究中描述了我们的经验。10名受试者在手术期间发生过敏反应,2名在内镜检查中发生,1名在经阴道超声检查中发生。其余两名受试者,1名在经阴道超声检查中,另1名在牙科手术期间发生了全身过敏反应。我们研究了所有患者在操作过程中使用的所有药物,包括乳胶、洗涤剂和消毒剂。3例手术在麻醉诱导时不得不暂停,5例手术未完成就停止了,2例手术完成。在内镜检查期间出现反应的两名患者均需要入住重症监护病房,其余患者在医院接受观察。手术过敏反应期间的责任药物为神经肌肉阻滞剂、乳胶、专利蓝和雷尼替丁。在内镜检查中确定为邻苯二甲醛(OPA);经阴道超声检查中为乳胶;牙科手术中为阿莫西林。本文的目的是回顾我们在研究全身麻醉和医疗操作期间的过敏全身反应和过敏反应方面的经验,强调这些反应的严重性以及识别致病药物的必要性。